HIIT increases MOTS-C production by up to 11.9 times in muscle tissue, activates AMPK pathways, and creates an "afterburn" effect that elevates metabolism for hours after the session
Data from a large retrospective cohort study to be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough Meeting showed that GLP-1 receptor agonist (GLP-1 RA) use was significantly associated with lower colorectal cancer incidence among patients with inflammatory bowel disease (IBD), including those with comorbid type 2 diabetes (T2D)
Rather, its typically the result of the quick and impressive weight loss they can cause in people
Its unique mechanism targets both GLP-1 and GIP receptors, helping to suppress appetite, slow digestion, and improve insulin sensitivity
According to WTWs 2024 survey, 52% of employers currently cover GLP-1s for weight loss, while 70% of non-covering employers say they might add coverage if prices drop